Rankings
▼
Calendar
FENC Q4 2018 Earnings — Fennec Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
FENC
Fennec Pharmaceuticals Inc.
$216M
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$3M
EPS (Diluted)
$-0.15
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
-$21,000
Balance Sheet
Total Assets
$23M
Total Liabilities
$2M
Stockholders' Equity
$21M
Cash & Equivalents
$23M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$3M
-$3M
-23.5%
Net Income
-$3M
-$2M
-30.3%
← FY 2018
All Quarters
Q1 2019 →